Brief: Organicell Announces Positive Results Of Initial Covid-19 Zofin™ Patient Trial In India And Trial Expansion
28/04/2021 12:59
April 28 (Reuters) - Organicell Regenerative Medicine Inc
BPSR.PK :
* ORGANICELL ANNOUNCES POSITIVE RESULTS OF INITIAL COVID-19
ZOFIN™
PATIENT TRIAL IN INDIA AND TRIAL EXPANSION
* ORGANICELL REGENERATIVE MEDICINE INC - ANNOUNCED POSITIVE
RESULTS FOR FIRST TEN COVID-19 PATIENTS TREATED WITH ZOFIN IN
INDIA
* ORGANICELL REGENERATIVE MEDICINE INC - ALL PATIENTS UNDER
TRIAL
HAVE RECOVERED FROM THEIR SYMPTOMS AND HAVE SINCE BEEN
DISCHARGED FROM HOSPITAL
* ORGANICELL REGENERATIVE - BASED ON INITIAL RESULTS OF
TRIAL,
TRIAL WILL BE EXPANDED TO ADDITIONAL SIXTY-FIVE PATIENTS WITH
MODERATE TO SEVERE COVID-19
* ORGANICELL - IF RESULTS OF EXPANDED TRIAL ARE SIMILARLY
POSITIVE, INTEND TO FILE FOR EUA TO USE ZOFIN IN INDIA AS
THERAPEUTIC FOR TREATING COVID-19
Source text for Eikon: ID:nBw2H8bHsa
Further company coverage: BPSR.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zeo Scientifix
See all newsBrief: Organicell Regenerative Says Zofin Therapy Approved By Pakistani Regulators To Be Used For A Covid-19 Patient On Compassionate Grounds
Brief: Organicell Begins Up-Listing Process On Nasdaq
Brief: Organicell Announces Positive Results Of Initial Covid-19 Zofin™ Patient Trial In India And Trial Expansion
Brief: Organicell Completes Enrollment For Its Expanded Access Trial To Treat Covid-19 Patients With Zofin™
Brief: Organicell Announces FDA Approval Of IND Application For Use Of Zofin In The Treatment Of Chronic Obstructive Pulmonary Disease